Onderneming Myovant Sciences Ltd.
Aandelen
MYOV
BMG637AM1024
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 579
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04-01-21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27-12-19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27-12-19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04-01-21 |
Director/Board Member | 59 | 22-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 97 235 316 | 46 097 791 ( 47,41 %) | 0 | 47,41 % |
Bedrijfsgegevens
Myovant Sciences Ltd.
11-12 St. James?s Square Suite 1, 3rd Floor
SW1Y 4LB, London
+
http://www.myovant.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,16% | 42,86 mld. | |
+11,12% | 42,74 mld. | |
+45,04% | 41,36 mld. | |
-8,83% | 27,68 mld. | |
+7,02% | 25,15 mld. | |
-23,87% | 18,63 mld. | |
+29,69% | 12,37 mld. | |
-2,43% | 11,92 mld. | |
+7,33% | 11,21 mld. |